PharmaCyte Biotech, Inc.
For the period ended Jul 31, 2025. Filed Sep 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 15, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1A. Risk Factors
The information called for by Item 1A is not required for a smaller reporting company. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K of the Company filed with the Commission on August 11, 2025.
During the three-months ended July 31, 2025, there were no shares issued.
Issuer Purchases of Equity Securities
During the three months ended July 31, 2025, there were no purchases of Equity Securities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.